Wells Fargo & Company MN boosted its stake in Becton Dickinson and Co (NYSE:BDX) by 0.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,565,101 shares of the medical instruments supplier’s stock after purchasing an additional 27,188 shares during the quarter. Wells Fargo & Company MN’s holdings in Becton Dickinson and were worth $930,491,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Acropolis Investment Management LLC acquired a new position in shares of Becton Dickinson and during the third quarter valued at about $101,000. Truvestments Capital LLC acquired a new position in shares of Becton Dickinson and during the third quarter valued at about $105,000. Almanack Investment Partners LLC. acquired a new position in shares of Becton Dickinson and during the second quarter valued at about $105,000. Bartlett & Co. LLC grew its holdings in shares of Becton Dickinson and by 2,900.0% during the second quarter. Bartlett & Co. LLC now owns 450 shares of the medical instruments supplier’s stock valued at $108,000 after buying an additional 435 shares during the last quarter. Finally, Bridgeworth LLC acquired a new position in shares of Becton Dickinson and during the second quarter valued at about $131,000. Institutional investors and hedge funds own 92.60% of the company’s stock.
BDX has been the subject of a number of analyst reports. Morgan Stanley lifted their price objective on shares of Becton Dickinson and from $250.00 to $280.00 and gave the company an “equal weight” rating in a report on Thursday, October 4th. KeyCorp reiterated a “buy” rating and set a $264.00 price objective on shares of Becton Dickinson and in a report on Friday, August 3rd. Citigroup lifted their price objective on shares of Becton Dickinson and from $274.00 to $283.00 and gave the company a “buy” rating in a report on Wednesday, August 8th. Barclays initiated coverage on shares of Becton Dickinson and in a report on Monday, October 15th. They set an “equal weight” rating and a $278.00 price objective for the company. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $248.00 price objective on shares of Becton Dickinson and in a report on Friday, August 3rd. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Becton Dickinson and currently has an average rating of “Buy” and a consensus price target of $256.14.
Becton Dickinson and stock opened at $236.29 on Monday. Becton Dickinson and Co has a fifty-two week low of $209.91 and a fifty-two week high of $265.87. The stock has a market cap of $63.03 billion, a P/E ratio of 24.93, a PEG ratio of 1.40 and a beta of 1.19. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.81 and a current ratio of 1.23.
About Becton Dickinson and
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems.
Recommended Story: How do investors use RSI to grade stocks?
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.